Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 1

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06139796Phase 1Withdrawn

Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV

Role: collaborator

NCT06302933Not ApplicableRecruiting

Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

Role: collaborator

NCT02043418Active Not Recruiting

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

Role: collaborator

NCT02570334Not ApplicableUnknown

A Cross Sectional Evaluation of the Development in Children Age 4 to 7 Infected or Exposed to HIV From the ANRS 12140 Cohort (Pediacam)

Role: collaborator

NCT00978172Phase 4Completed

Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria

Role: collaborator

All 5 trials loaded